Pharma Marketing News | Subscribe | Discussion Forums | Roundtable | Podcasts | Blog
Daily News Briefs | Surveys | Resources/Links | Glossary | Case Studies | Reports
Pharma Marketing Vendor Directory | Conference Calendar | Pharma Jobs
Advertising Information | FAQs | About Us | Privacy Policy

---

SUMMARY

As catalysts of collaborative relationships and scientific knowledge exchange, medical science liaisons (MSLs) are immersed in intangible value contribution that often require lengthy business cycles and vesting terms. Now, 40 years since the inception of the MSL concept by Upjohn in 1967, industryÂ’s MSL programs face the same challenges that knowledge programs like strategy and competitive intelligence face: how do you measure the value of science and collaborative processes required to develop scientific ideas into practical reality and competitive advantage? This article by Dr. Jane Chin of the Medical Science Liaison Institute, offers suggestions for MSL metrics based on results of a consensus survey.

Topics and issues covered include:

• Measuring the Value of Science
• Evidence-based Metrics
• Medical Science Liaison Metrics Consensus
• MSL Activities Across the Product Development Spectrum
• Interaction with Thought Leaders
• MSLs at Launch and Beyond
• Clinical Study Milestones
• Satisfaction Surveys
• Measure Quality, Not Quantity, of IIT Proposals
• Problem with Reach and Frequency Metrics

ONLY $9.95
Download PDF file immediately after paying:

PMN65-01
Issue: Vol. 6, No. 5: May 2007
Word Count: 2354

Find other articles in related Topic Areas:

• Physician Education (CME)
• MSLs and KOL Management
• Regulatory Compliance